81 related articles for article (PubMed ID: 10391554)
1. Association between ratio of matrix metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Simon MA; Peabody TD; Getty PJ
J Bone Joint Surg Am; 1999 Jun; 81(6):893-5. PubMed ID: 10391554
[No Abstract] [Full Text] [Related]
2. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Berend KR; Toth AP; Harrelson JM; Layfield LJ; Hey LA; Scully SP
J Bone Joint Surg Am; 1998 Jan; 80(1):11-7. PubMed ID: 9469303
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.
Yin H; Zhou W; Meng J; Zhang D; Wu Z; Wang T; Wang J; Wang P; Shi X; Wu S; Zhao J; Xiao J
Ann Surg Oncol; 2014 Oct; 21(11):3572-8. PubMed ID: 24833099
[TBL] [Abstract][Full Text] [Related]
4. Chondrosarcoma of bone: a statistical analysis of prognostic factors.
Wang JW; Ger LP; Shih CH; Hsieh MC
J Formos Med Assoc; 1991 Oct; 90(10):998-1003. PubMed ID: 1685183
[TBL] [Abstract][Full Text] [Related]
5. No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990.
Söderström M; Ekfors TO; Böhling TO; Teppo LH; Vuorio EI; Aro HT
Acta Orthop Scand; 2003 Jun; 74(3):344-50. PubMed ID: 12899557
[TBL] [Abstract][Full Text] [Related]
6. Does local recurrence impact survival in low-grade chondrosarcoma of the long bones?
Schwab JH; Wenger D; Unni K; Sim FH
Clin Orthop Relat Res; 2007 Sep; 462():175-80. PubMed ID: 17514007
[TBL] [Abstract][Full Text] [Related]
7. Oncologic impact of the curettage of grade 2 central chondrosarcoma of the extremity.
Cho WH; Song WS; Jeon DG; Kong CB; Koh JS; Kim JI; Lee SY
Ann Surg Oncol; 2011 Dec; 18(13):3755-61. PubMed ID: 21611858
[TBL] [Abstract][Full Text] [Related]
8. Survivorship analysis in patients with periosteal chondrosarcoma.
Papagelopoulos PJ; Galanis EC; Mavrogenis AF; Savvidou OD; Bond JR; Unni KK; Sim FH
Clin Orthop Relat Res; 2006 Jul; 448():199-207. PubMed ID: 16826117
[TBL] [Abstract][Full Text] [Related]
9. [Chondrosarcoma. A prognostic assessment on basis of 19 cases].
Dissing I; Heerfordt J; Schiødt T; Sneppen O
Ugeskr Laeger; 1978 Jul; 140(27):1609-12. PubMed ID: 684899
[No Abstract] [Full Text] [Related]
10. Survival analysis of patients with chondrosarcomas of the pelvis.
Mavrogenis AF; Angelini A; Drago G; Merlino B; Ruggieri P
J Surg Oncol; 2013 Jul; 108(1):19-27. PubMed ID: 23681650
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.
Häckel CG; Krueger S; Grote HJ; Oshiro Y; Hodges S; Johnston DA; Johnson ME; Roessner A; Ayala AG; Czerniak B
Cancer; 2000 Sep; 89(5):995-1003. PubMed ID: 10964329
[TBL] [Abstract][Full Text] [Related]
12. [The comparative biochemical and morphological characteristics of chondrosarcoma and giant-cell tumor of the bone].
Akbasheva OE; Shchepetkin IA; Vasil'ev NV; Zheravin AA; Anisenia II; Buél' EV; Zhukova IaA
Vopr Onkol; 2000; 46(3):298-301. PubMed ID: 10976275
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
Hou CH; Hsiao YC; Fong YC; Tang CH
Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
[TBL] [Abstract][Full Text] [Related]
14. [Chondrosarcoma--an easily treatable tumor?].
Donow C; Wippermann B; Schratt E; Tscherne H
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():918-20. PubMed ID: 9102025
[No Abstract] [Full Text] [Related]
15. Do pathological fractures influence survival and local recurrence rate in bony sarcomas?
Bramer JA; Abudu AA; Grimer RJ; Carter SR; Tillman RM
Eur J Cancer; 2007 Sep; 43(13):1944-51. PubMed ID: 17698347
[TBL] [Abstract][Full Text] [Related]
16. The role of grade in local recurrence and the disease-specific survival in chondrosarcomas.
Laitinen MK; Stevenson JD; Parry MC; Sumathi V; Grimer RJ; Jeys LM
Bone Joint J; 2018 May; 100-B(5):662-666. PubMed ID: 29701096
[TBL] [Abstract][Full Text] [Related]
17. [Calmodulin level in chondrosarcomas].
Kushlinskiĭ NE; Solov'ev IuN; Galkina NM; Aliev MD; Kharatishvili TK; Babkina NV; Berezov TT; Trapeznikov NN
Biull Eksp Biol Med; 2000 Feb; 129(2):198-200. PubMed ID: 10732246
[No Abstract] [Full Text] [Related]
18. Chondrosarcoma of the pelvis and upper end of the femur. An analysis of factors influencing survival time in one hundred and thirteen cases.
Marcove RC; Miké V; Hutter RV; Huvos AG; Shoji H; Miller TR; Kosloff R
J Bone Joint Surg Am; 1972 Apr; 54(3):561-72. PubMed ID: 5055153
[No Abstract] [Full Text] [Related]
19. [Prognostic significance of p53, HER-2/neu, Ki-67 and VEGF expression in chondrosarcomas].
Stepanova EV; Kharatishvili TK; Lichinitser MR; Baryshnikov AIu; Solov'ev IuN; Trapeznikov NN
Arkh Patol; 2002; 64(6):9-12. PubMed ID: 12534219
[TBL] [Abstract][Full Text] [Related]
20. Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli.
Gitelis S; Bertoni F; Picci P; Campanacci M
J Bone Joint Surg Am; 1981 Oct; 63(8):1248-57. PubMed ID: 7287795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
